Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 604 entries
Sorted by: Best Match Show Resources per page
Foreword to the proceedings of the 8th international ALPD symposium, New Delhi, India, November 15-17, 2013.

Hepatology international

[No authors listed]
PMID: 26201317
Hepatol Int. 2014 Sep;8:407. doi: 10.1007/s12072-014-9579-8.

No abstract available.

Cite
Foreword to the proceedings of the 8th international ALPD symposium, New Delhi, India, November 15-17, 2013. Hepatol Int. 2014;8:407doi: 10.1007/s12072-014-9579-8.
(2014). Foreword to the proceedings of the 8th international ALPD symposium, New Delhi, India, November 15-17, 2013. Hepatology international, 8407. https://doi.org/10.1007/s12072-014-9579-8
"Foreword to the proceedings of the 8th international ALPD symposium, New Delhi, India, November 15-17, 2013." Hepatology international vol. 8 (2014): 407. doi: https://doi.org/10.1007/s12072-014-9579-8
Foreword to the proceedings of the 8th international ALPD symposium, New Delhi, India, November 15-17, 2013. Hepatol Int. 2014 Sep;8:407. doi: 10.1007/s12072-014-9579-8. PMID: 26201317.
Copy Download .nbib Format: NLM
Erratum to: Epigenetic histone modifications in a clinically relevant rat model of chronic ethanol-binge-mediated liver injury.

Hepatology international

Aroor AR, Restrepo RJ, Kharbanda KK, Shukla SD.
PMID: 26201321
Hepatol Int. 2014 Sep;8:431. doi: 10.1007/s12072-014-9564-2.

No abstract available.

Cite
Aroor AR, Restrepo RJ, Kharbanda KK, et al. Erratum to: Epigenetic histone modifications in a clinically relevant rat model of chronic ethanol-binge-mediated liver injury. Hepatol Int. 2014;8:431doi: 10.1007/s12072-014-9564-2.
Aroor, A. R., Restrepo, R. J., Kharbanda, K. K., & Shukla, S. D. (2014). Erratum to: Epigenetic histone modifications in a clinically relevant rat model of chronic ethanol-binge-mediated liver injury. Hepatology international, 8431. https://doi.org/10.1007/s12072-014-9564-2
Aroor, Annayya R, et al. "Erratum to: Epigenetic histone modifications in a clinically relevant rat model of chronic ethanol-binge-mediated liver injury." Hepatology international vol. 8 (2014): 431. doi: https://doi.org/10.1007/s12072-014-9564-2
Aroor AR, Restrepo RJ, Kharbanda KK, Shukla SD. Erratum to: Epigenetic histone modifications in a clinically relevant rat model of chronic ethanol-binge-mediated liver injury. Hepatol Int. 2014 Sep;8:431. doi: 10.1007/s12072-014-9564-2. PMID: 26201321.
Copy Download .nbib Format: NLM
Hepatocyte-mediated cytotoxicity and host defense mechanisms in the alcohol-injured liver.

Hepatology international

McVicker BL, Thiele GM, Tuma DJ, Casey CA.
PMID: 26201322
Hepatol Int. 2014 Sep;8:432-8. doi: 10.1007/s12072-013-9511-7. Epub 2013 Dec 29.

The consumption of alcohol is associated with many health issues including alcoholic liver disease (ALD). The natural history of ALD involves the development of steatosis, inflammation (steatohepatitis), fibrosis and cirrhosis. During the stage of steatohepatitis, the combination of inflammation...

Cite
McVicker BL, Thiele GM, Tuma DJ, et al. Hepatocyte-mediated cytotoxicity and host defense mechanisms in the alcohol-injured liver. Hepatol Int. 2013;8:432-8doi: 10.1007/s12072-013-9511-7.
McVicker, B. L., Thiele, G. M., Tuma, D. J., & Casey, C. A. (2014). Hepatocyte-mediated cytotoxicity and host defense mechanisms in the alcohol-injured liver. Hepatology international, 8432-8. https://doi.org/10.1007/s12072-013-9511-7
McVicker, Benita L, et al. "Hepatocyte-mediated cytotoxicity and host defense mechanisms in the alcohol-injured liver." Hepatology international vol. 8 (2014): 432-8. doi: https://doi.org/10.1007/s12072-013-9511-7
McVicker BL, Thiele GM, Tuma DJ, Casey CA. Hepatocyte-mediated cytotoxicity and host defense mechanisms in the alcohol-injured liver. Hepatol Int. 2014 Sep;8:432-8. doi: 10.1007/s12072-013-9511-7. Epub 2013 Dec 29. PMID: 26201322.
Copy Download .nbib Format: NLM
Immunity and inflammatory signaling in alcoholic liver disease.

Hepatology international

Mandrekar P, Ambade A, Wen ZA, Zhao Y.
PMID: 26201323
Hepatol Int. 2014 Sep;8:439-46. doi: 10.1007/s12072-014-9518-8. Epub 2014 Mar 28.

The pathogenesis of alcoholic liver disease (ALD) is multifactorial and characterized by steatosis, steatohepatitis and cirrhosis. Several signaling pathways in different liver cell types that contribute to the development and progression of alcoholic liver injury have been identified. Among...

Cite
Mandrekar P, Ambade A, Wen ZA, et al. Immunity and inflammatory signaling in alcoholic liver disease. Hepatol Int. 2014;8:439-46doi: 10.1007/s12072-014-9518-8.
Mandrekar, P., Ambade, A., Wen, Z. A., & Zhao, Y. (2014). Immunity and inflammatory signaling in alcoholic liver disease. Hepatology international, 8439-46. https://doi.org/10.1007/s12072-014-9518-8
Mandrekar, Pranoti, et al. "Immunity and inflammatory signaling in alcoholic liver disease." Hepatology international vol. 8 (2014): 439-46. doi: https://doi.org/10.1007/s12072-014-9518-8
Mandrekar P, Ambade A, Wen ZA, Zhao Y. Immunity and inflammatory signaling in alcoholic liver disease. Hepatol Int. 2014 Sep;8:439-46. doi: 10.1007/s12072-014-9518-8. Epub 2014 Mar 28. PMID: 26201323; PMCID: PMC4587491.
Copy Download .nbib Format: NLM
Recent insights into hepatic cancer stem cells.

Hepatology international

Anfuso B, Tiribelli C, Sukowati CH.
PMID: 26201324
Hepatol Int. 2014 Sep;8:458-63. doi: 10.1007/s12072-013-9498-0. Epub 2013 Dec 20.

It has been suggested that the development of hepatocellular carcinoma (HCC) is related to the existence of cancer stem cells (CSCs) or tumor-initiating cells. Although CSCs populations may be recognized by use of stem cell markers and/or their functional...

Cite
Anfuso B, Tiribelli C, Sukowati CH. Recent insights into hepatic cancer stem cells. Hepatol Int. 2013;8:458-63doi: 10.1007/s12072-013-9498-0.
Anfuso, B., Tiribelli, C., & Sukowati, C. H. (2014). Recent insights into hepatic cancer stem cells. Hepatology international, 8458-63. https://doi.org/10.1007/s12072-013-9498-0
Anfuso, Beatrice, et al. "Recent insights into hepatic cancer stem cells." Hepatology international vol. 8 (2014): 458-63. doi: https://doi.org/10.1007/s12072-013-9498-0
Anfuso B, Tiribelli C, Sukowati CH. Recent insights into hepatic cancer stem cells. Hepatol Int. 2014 Sep;8:458-63. doi: 10.1007/s12072-013-9498-0. Epub 2013 Dec 20. PMID: 26201324.
Copy Download .nbib Format: NLM
Erratum to: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update.

Hepatology international

Liaw YF, Kao JH, Piratvisuth T, Chan HL, Chien RN, Liu CJ, Gane E, Locarnini S, Lim SG, Han KH, Amarapurkar D, Cooksley G, Jafri W, Mohamed R, Hou JL, Chuang WL, Lesmana LA, Sollano JD, Suh DJ, Omata M.
PMID: 26201529
Hepatol Int. 2012 Oct;6(4):809-10. doi: 10.1007/s12072-012-9386-z.

No abstract available.

Cite
Liaw YF, Kao JH, Piratvisuth T, et al. Erratum to: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol Int. 2012;6(4):809-10doi: 10.1007/s12072-012-9386-z.
Liaw, Y. F., Kao, J. H., Piratvisuth, T., Chan, H. L., Chien, R. N., Liu, C. J., Gane, E., Locarnini, S., Lim, S. G., Han, K. H., Amarapurkar, D., Cooksley, G., Jafri, W., Mohamed, R., Hou, J. L., Chuang, W. L., Lesmana, L. A., Sollano, J. D., Suh, D. J., & Omata, M. (2012). Erratum to: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatology international, 6(4), 809-10. https://doi.org/10.1007/s12072-012-9386-z
Liaw, Yun-Fan, et al. "Erratum to: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update." Hepatology international vol. 6,4 (2012): 809-10. doi: https://doi.org/10.1007/s12072-012-9386-z
Liaw YF, Kao JH, Piratvisuth T, Chan HL, Chien RN, Liu CJ, Gane E, Locarnini S, Lim SG, Han KH, Amarapurkar D, Cooksley G, Jafri W, Mohamed R, Hou JL, Chuang WL, Lesmana LA, Sollano JD, Suh DJ, Omata M. Erratum to: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol Int. 2012 Oct;6(4):809-10. doi: 10.1007/s12072-012-9386-z. PMID: 26201529.
Copy Download .nbib Format: NLM
Adenoviral gene therapy in hepatocellular carcinoma: a review.

Hepatology international

Lyra-González I, Flores-Fong LE, González-García I, Medina-Preciado D, Armendáriz-Borunda J.
PMID: 26201621
Hepatol Int. 2013 Mar;7(1):48-58. doi: 10.1007/s12072-012-9367-2. Epub 2012 Apr 25.

BACKGROUND: Hepatocellular carcinoma is the third leading cause of cancer death. Single or multiple mutations in genes related to growth control, apoptosis, invasion and metastasis have been determined; so a better understanding of the molecular genetic basis of malignant...

Cite
Lyra-González I, Flores-Fong LE, González-García I, et al. Adenoviral gene therapy in hepatocellular carcinoma: a review. Hepatol Int. 2012;7(1):48-58doi: 10.1007/s12072-012-9367-2.
Lyra-González, I., Flores-Fong, L. E., González-García, I., Medina-Preciado, D., & Armendáriz-Borunda, J. (2013). Adenoviral gene therapy in hepatocellular carcinoma: a review. Hepatology international, 7(1), 48-58. https://doi.org/10.1007/s12072-012-9367-2
Lyra-González, Iván, et al. "Adenoviral gene therapy in hepatocellular carcinoma: a review." Hepatology international vol. 7,1 (2013): 48-58. doi: https://doi.org/10.1007/s12072-012-9367-2
Lyra-González I, Flores-Fong LE, González-García I, Medina-Preciado D, Armendáriz-Borunda J. Adenoviral gene therapy in hepatocellular carcinoma: a review. Hepatol Int. 2013 Mar;7(1):48-58. doi: 10.1007/s12072-012-9367-2. Epub 2012 Apr 25. PMID: 26201621.
Copy Download .nbib Format: NLM
Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease.

Hepatology international

Wah-Kheong C, Khean-Lee G.
PMID: 26201622
Hepatol Int. 2013 Mar;7(1):65-71. doi: 10.1007/s12072-012-9384-1. Epub 2012 Jun 15.

Non-alcoholic fatty liver disease (NAFLD) is rapidly increasing in the Asia-Pacific and affects up to 30 % of the general population. In younger children, prevalence has been reported to be between 2.1 and 4.5 %. The prevalence of NAFLD...

Cite
Wah-Kheong C, Khean-Lee G. Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease. Hepatol Int. 2012;7(1):65-71doi: 10.1007/s12072-012-9384-1.
Wah-Kheong, C., & Khean-Lee, G. (2013). Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease. Hepatology international, 7(1), 65-71. https://doi.org/10.1007/s12072-012-9384-1
Wah-Kheong, Chan, and Khean-Lee, Goh. "Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease." Hepatology international vol. 7,1 (2013): 65-71. doi: https://doi.org/10.1007/s12072-012-9384-1
Wah-Kheong C, Khean-Lee G. Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease. Hepatol Int. 2013 Mar;7(1):65-71. doi: 10.1007/s12072-012-9384-1. Epub 2012 Jun 15. PMID: 26201622.
Copy Download .nbib Format: NLM
Autoimmune acute liver failure: an emerging etiology for intractable acute liver failure.

Hepatology international

Fujiwara K, Yasui S, Yokosuka O.
PMID: 26201768
Hepatol Int. 2013 Jun;7(2):335-46. doi: 10.1007/s12072-012-9402-3. Epub 2012 Sep 28.

Diagnosis of acute onset autoimmune hepatitis (AIH) is the most challenging task because of atypical clinicopathological features. We examined the nature of acute onset AIH consisting of nonsevere, severe, and fulminant AIH based on our published data and other...

Cite
Fujiwara K, Yasui S, Yokosuka O. Autoimmune acute liver failure: an emerging etiology for intractable acute liver failure. Hepatol Int. 2012;7(2):335-46doi: 10.1007/s12072-012-9402-3.
Fujiwara, K., Yasui, S., & Yokosuka, O. (2013). Autoimmune acute liver failure: an emerging etiology for intractable acute liver failure. Hepatology international, 7(2), 335-46. https://doi.org/10.1007/s12072-012-9402-3
Fujiwara, Keiichi, et al. "Autoimmune acute liver failure: an emerging etiology for intractable acute liver failure." Hepatology international vol. 7,2 (2013): 335-46. doi: https://doi.org/10.1007/s12072-012-9402-3
Fujiwara K, Yasui S, Yokosuka O. Autoimmune acute liver failure: an emerging etiology for intractable acute liver failure. Hepatol Int. 2013 Jun;7(2):335-46. doi: 10.1007/s12072-012-9402-3. Epub 2012 Sep 28. PMID: 26201768.
Copy Download .nbib Format: NLM
Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B.

Hepatology international

Chen YP, Peng J, Hou JL.
PMID: 26201770
Hepatol Int. 2013 Jun;7(2):356-68. doi: 10.1007/s12072-013-9439-y. Epub 2013 May 17.

In patients with chronic hepatitis B (CHB), liver fibrosis assessment is essential not only for determining prognosis but also for identifying patients who should receive treatment. Liver biopsy is limited by its invasiveness and sampling error. To explore effective...

Cite
Chen YP, Peng J, Hou JL. Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B. Hepatol Int. 2013;7(2):356-68doi: 10.1007/s12072-013-9439-y.
Chen, Y. P., Peng, J., & Hou, J. L. (2013). Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B. Hepatology international, 7(2), 356-68. https://doi.org/10.1007/s12072-013-9439-y
Chen, Yong-Peng, et al. "Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B." Hepatology international vol. 7,2 (2013): 356-68. doi: https://doi.org/10.1007/s12072-013-9439-y
Chen YP, Peng J, Hou JL. Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B. Hepatol Int. 2013 Jun;7(2):356-68. doi: 10.1007/s12072-013-9439-y. Epub 2013 May 17. PMID: 26201770.
Copy Download .nbib Format: NLM
Role of anticoagulant therapy in liver disease.

Hepatology international

Plompen EP, Schouten JN, Janssen HL.
PMID: 26201771
Hepatol Int. 2013 Jun;7(2):369-76. doi: 10.1007/s12072-013-9427-2. Epub 2013 Mar 26.

Anticoagulant therapy is a cornerstone in the treatment of different liver diseases. In Budd-Chiari syndrome (BCS), survival rates have increased considerably since the introduction of a treatment strategy in which anticoagulation is the treatment of first choice. In all...

Cite
Plompen EP, Schouten JN, Janssen HL. Role of anticoagulant therapy in liver disease. Hepatol Int. 2013;7(2):369-76doi: 10.1007/s12072-013-9427-2.
Plompen, E. P., Schouten, J. N., & Janssen, H. L. (2013). Role of anticoagulant therapy in liver disease. Hepatology international, 7(2), 369-76. https://doi.org/10.1007/s12072-013-9427-2
Plompen, Elisabeth P C, et al. "Role of anticoagulant therapy in liver disease." Hepatology international vol. 7,2 (2013): 369-76. doi: https://doi.org/10.1007/s12072-013-9427-2
Plompen EP, Schouten JN, Janssen HL. Role of anticoagulant therapy in liver disease. Hepatol Int. 2013 Jun;7(2):369-76. doi: 10.1007/s12072-013-9427-2. Epub 2013 Mar 26. PMID: 26201771.
Copy Download .nbib Format: NLM
The risk factors and diagnosis of cholangiocarcinoma.

Hepatology international

Wadsworth CA, Lim A, Taylor-Robinson SD, Khan SA.
PMID: 26201772
Hepatol Int. 2013 Jun;7(2):377-93. doi: 10.1007/s12072-012-9407-y. Epub 2012 Nov 10.

Cholangiocarcinoma (CC) is a generally fatal malignancy of the biliary tree. Its incidence is increasing worldwide. Unfortunately, the diagnosis of CC frequently occurs late in the course of the disease, which contributes to the high mortality rate. Securing the...

Cite
Wadsworth CA, Lim A, Taylor-Robinson SD, et al. The risk factors and diagnosis of cholangiocarcinoma. Hepatol Int. 2012;7(2):377-93doi: 10.1007/s12072-012-9407-y.
Wadsworth, C. A., Lim, A., Taylor-Robinson, S. D., & Khan, S. A. (2013). The risk factors and diagnosis of cholangiocarcinoma. Hepatology international, 7(2), 377-93. https://doi.org/10.1007/s12072-012-9407-y
Wadsworth, Christopher A, et al. "The risk factors and diagnosis of cholangiocarcinoma." Hepatology international vol. 7,2 (2013): 377-93. doi: https://doi.org/10.1007/s12072-012-9407-y
Wadsworth CA, Lim A, Taylor-Robinson SD, Khan SA. The risk factors and diagnosis of cholangiocarcinoma. Hepatol Int. 2013 Jun;7(2):377-93. doi: 10.1007/s12072-012-9407-y. Epub 2012 Nov 10. PMID: 26201772.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 604 entries